DNA damage response is prominent in ovarian high-grade serous carcinomas, especially those with Rsf-1 (HBXAP) overexpression

Journal of Oncology

Volumn , Issue , 2012, Pages

  Kshirsagar, Malti ^a   Jiang, Wei ^a,b   Shih, Ie Ming ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHECKPOINT KINASE 2; THREONINE;

ARTICLE; CANCER TISSUE; CHROMATIN ASSEMBLY AND DISASSEMBLY; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; DNA DAMAGE; FEMALE; GENE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; OVARY CARCINOMA; OVARY CYST; PROTEIN BLOOD LEVEL; PROTEIN PHOSPHORYLATION; RSF 1 GENE; UTERINE TUBE;

EID: 84855323078     PISSN: 16878450     EISSN: 16878469     Source Type: Journal    
DOI: 10.1155/2012/621685     Document Type: Article

References (41)

1. Cho K. R., Shih I. M., Ovarian cancer Annual Review of Pathology 2009 4 287 313
2. Kbel M., Kalloger S. E., Boyd N., McKinney S., Mehl E., Palmer C., Leung S., Bowen N. J., Ionescu D. N., Rajput A., Prentice L. M., Miller D., Santos J., Swenerton K., Gilks C. B., Huntsman D., Ovarian carcinoma subtypes are different diseases: implications for biomarker studies PLoS Medicine 2008 5 12, article e232
3. Shih I. M., Kurman R. J., Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis American Journal of Pathology 2004 164 5 1511 1518 (Pubitemid 38529752)
4. Oka K., Tanaka T., Enoki T., Yoshimura K., Ohshima M., Kubo M., Murakami T., Gondou T., Minami Y., Takemoto Y., Harada E., Tsushimi T., Li T. S., Traganos F., Darzynkiewicz Z., Hamano K., DNA damage signaling is activated during cancer progression in human colorectal carcinoma Cancer Biology and Therapy 2010 9 3 246 252
5. Koorstra J. B. M., Hong S. M., Shi C., Meeker A. K., Ryu J. K., Offerhaus G. J. A., Goggins M. G., Hruban R. H., Maitra A., Widespread activation of the DNA damage response in human pancreatic intraepithelial neoplasia Modern Pathology 2009 22 11 1439 1445
6. Yoon A. J., Shen J., Santella R. M., Zegarelli D. J., Chen R., Weinstein I. B., Activated checkpoint kinase 2 expression and risk for oral squamous cell carcinoma Cancer Epidemiology Biomarkers and Prevention 2007 16 12 2768 2772 (Pubitemid 351196335)
7. Al-Ejeh F., Kumar R., Wiegmans A., Lakhani S. R., Brown M. P., Khanna K. K., Harnessing the complexity of DNA-damage response pathways to improve cancer treatment outcomes Oncogene 2010 29 46 6085 6098
8. Harper J. W., Elledge S. J., The DNA damage response: ten years after Molecular Cell 2007 28 5 739 745 (Pubitemid 350217064)
9. Stracker T. H., Usui T., Petrini J. H. J., Taking the time to make important decisions: the checkpoint effector kinases Chk1 and Chk2 and the DNA damage response DNA Repair 2009 8 9 1047 1054
10. Matsuoka S., Huang M., Elledge S. J., Linkage of ATM to cell cycle regulation by the Chk2 protein kinase Science 1998 282 5395 1893 1897 (Pubitemid 28555269)
11. Falck J., Mailand N., Syljusen R. G., Bartek J., Lukas J., The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis Nature 2001 410 6830 842 847 (Pubitemid 32303786)
12. Ward I. M., Wu X., Chen J., Threonine 68 of Chk2 is phosphorylated at sites of DNA strand breaks Journal of Biological Chemistry 2001 276 51 47755 47758
13. Yoon A. J., Shen J., Wu H. C., Angelopoulos C., Singer S. R., Chen R., Santella R. M., Expression of activated checkpoint kinase 2 and histone 2AX in exfoliative oral cells after exposure to ionizing radiation Radiation Research 2009 171 6 771 775
14. Stefanidis K., Loutradis D., Vassiliou L. V., Anastasiadou V., Kiapekou E., Nikas V., Patris G., Vlachos G., Rodolakis A., Antsaklis A., Nevirapine induces growth arrest and premature senescence in human cervical carcinoma cells Gynecologic Oncology 2008 111 2 344 349
15. DiTullio R. A., Mochan T. A., Venere M., Bartkova J., Sehested M., Bartek J., Halazonetis T. D., 53BP1 functions in a ATM-dependent checkpoint pathway that is constitutively activated in human cancer Nature Cell Biology 2002 4 12 998 1002 (Pubitemid 35469432)
16. Shih I. M., Sheu J. J. C., Santillan A., Nakayama K., Yen M. J., Bristow R. E., Vang R., Parmigiani G., Kurman R. J., Trope C. G., Davidson B., Wang T. L., Amplification of a chromatin remodeling gene, Rsf-1/HBXAP, in ovarian carcinoma Proceedings of the National Academy of Sciences of the United States of America 2005 102 39 14004 14009 (Pubitemid 41377693)
17. Mao T. L., Hsu C. Y., Yen M. J., Gilks B., Sheu J. J. C., Gabrielson E., Vang R., Cope L., Kurman R. J., Wang T. L., Shih I. M., Expression of Rsf-1, a chromatin-remodeling gene, in ovarian and breast carcinoma Human Pathology 2006 37 9 1169 1175 (Pubitemid 44286982)
18. Nakayama K., Nakayama N., Jinawath N., Salani R., Kurman R. J., Shih I. M., Wang T. L., Amplicon profiles in ovarian serous carcinomas International Journal of Cancer 2007 120 12 2613 2617 (Pubitemid 46651282)
19. Lukas C., Falck J., Bartkova J., Bartek J., Lukas J., Distinct spatiotemporal dynamics of mammalian checkpoint regulators induced by DNA damage Nature Cell Biology 2003 5 3 255 260 (Pubitemid 36322254)
20. Sheu J. J. C., Guan B., Choi J. H., Lin A., Lee C. H., Hsiao Y. T., Wang T. L., Tsai F. J., Shih I. M., Rsf-1, a chromatin remodeling protein, induces DNA damage and promotes genomic instability Journal of Biological Chemistry 2010 285 49 38260 38269
21. Gorgoulis V. G., Vassiliou L. V. F., Karakaidos P., Zacharatos P., Kotsinas A., Liloglou T., Venere M., DiTullio R. A., Kastrinakis N. G., Levy B., Kletsas D., Yoneta A., Herlyn M., Kittas C., Halazonetis T. D., Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions Nature 2005 434 7035 907 913 (Pubitemid 40559004)
22. Bartkova J., Hoej Z., Koed K., Krmer A., Tort F., Zleger K., Guldberg P., Sehested M., Nesland J. M., Lukas C., Orntoft T., Lukas J., Bartek J., DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis Nature 2005 434 7035 864 870 (Pubitemid 40558993)
23. Bartkova J., Rezaei N., Liontos M., Karakaidos P., Kletsas D., Issaeva N., Vassiliou L. V. F., Kolettas E., Niforou K., Zoumpourlis V. C., Takaoka M., Nakagawa H., Tort F., Fugger K., Johansson F., Sehested M., Andersen C. L., Dyrskjot L., rntoft T., Lukas J., Kittas C., Helleday T., Halazonetis T. D., Bartek J., Gorgoulis V. G., Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints Nature 2006 444 7119 633 637 (Pubitemid 44864442)
24. Di Micco R., Fumagalli M., Cicalese A., Piccinin S., Gasparini P., Luise C., Schurra C., Garré M., Giovanni Nuciforo P., Bensimon A., Maestro R., Giuseppe Pelicci P., D'Adda Di Fagagna F., Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication Nature 2006 444 7119 638 642 (Pubitemid 44864443)
25. Kindelberger D. W., Lee Y., Miron A., Hirsch M. S., Feltmate C., Medeiros F., Callahan M. J., Garner E. O., Gordon R. W., Birch C., Berkowitz R. S., Muto M. G., Crum C. P., Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship American Journal of Surgical Pathology 2007 31 2 161 169 (Pubitemid 46175016)
26. Crum C. P., Drapkin R., Miron A., Ince T. A., Muto M., Kindelberger D. W., Lee Y., The distal fallopian tube: a new model for pelvic serous carcinogenesis Current Opinion in Obstetrics and Gynecology 2007 19 1 3 9 (Pubitemid 46095865)
27. Kurman R. J., Shih I. M., The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory American Journal of Surgical Pathology 2010 34 3 433 443
28. Visvanathan K., Gross A. L., Kurman R. J., Vang R., Shih I. M., Precursor lesions of high-grade serous ovarian carcinoma: morphological and molecular characteristics Journal of Oncology 2010
29. Salvador S., Gilks B., Kbel M., Huntsman D., Rosen B., Miller D., The fallopian tube: primary site of most pelvic high-grade serous carcinomas International Journal of Gynecological Cancer 2009 19 1 58 64
30. Singer G., Kurman R. J., Chang H. W., Cho S. K. R., Shih I. M., Diverse tumorigenic pathways in ovarian serous carcinoma American Journal of Pathology 2002 160 4 1223 1228 (Pubitemid 34411626)
31. Singer G., Oldt R. III, Cohen Y., Wang B. G., Sidransky D., Kurman R. J., Shih I. M., Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma Journal of the National Cancer Institute 2003 95 6 484 486 (Pubitemid 36432423)
32. Nakayama K., Nakayama N., Kurman R. J., Cope L., Pohl G., Samuels Y., Velculescu V. E., Wang T. L., Shih I. M., Sequence mutations and amplification of PIK3CA and AKT2 genes in purified ovarian serous neoplasms Cancer Biology and Therapy 2006 5 7 779 785 (Pubitemid 44775134)
33. Jones S., Wang T. L., Shih I. M., Mao T. L., Nakayama K., Roden R., Glas R., Slamon D., Diaz L. A., Vogelstein B., Kinzler K. W., Velculescu V. E., Papadopoulos N., Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma Science 2010 330 6001 228 231
34. Meinhold-Heerlein I., Bauerschlag D., Hilpert F., Dimitrov P., Sapinoso L. M., Orlowska-Volk M., Bauknecht T., Park T. W., Jonat W., Jacobsen A., Sehouli J., Luttges J., Krajewski M., Krajewski S., Reed J. C., Arnold N., Hampton G. M., Molecular and prognostic distinction between serous ovarian carcinomas of varying grade and malignant potential Oncogene 2005 24 6 1053 1065 (Pubitemid 40313882)
35. Shih I.-M., Chen L., Wang C. C., Distinct DNA methylation profiles in ovarian sreous neoplasms and their implications in ovarian carcinogenesis American Journal of Obstetrics Gynecology 2010 203 6 584.e1 584.e22
36. Kerzendorfer C., O'Driscoll M., Human DNA damage response and repair deficiency syndromes: linking genomic instability and cell cycle checkpoint proficiency DNA Repair 2009 8 9 1139 1152
37. Lydall D., Taming the tiger by the tail: modulation of DNA damage responses by telomeres EMBO Journal 2009 28 15 2174 2187
38. Halazonetis T. D., Gorgoulis V. G., Bartek J., An oncogene-induced DNA damage model for cancer development Science 2008 319 5868 1352 1355 (Pubitemid 351354863)
39. Kuo K. T., Mao T. L., Feng Y., Chen X., Nakayama K., Wang Y., Glas R., Ma M. J., Kurman R. J., Shih I. M., Wang T. L., DNA copy numbers profiles in affinity-purified ovarian clear cell carcinoma Clinical Cancer Research 2010 16 7 1997 2008
40. Kuo K. T., Guan B., Feng Y., Mao T. L., Chen X., Jinawath N., Wang Y., Kurman R. J., Shih I. M., Wang T. L., Analysis of DNA copy number alterations in ovarian serous tumors identifies new molecular genetic changes in low-grade and high-grade carcinomas Cancer Research 2009 69 9 4036 4042
41. Anderson V. E., Walton M. I., Eve P. D., Boxall K. J., Antoni L., Caldwell J. J., Aherne W., Pearl L. H., Oliver A. W., Collins I., Garrett M. D., CCT241533 is a potent and selective inhibitor of CHK2 that potentiates the cytotoxicity of PARP inhibitors Cancer Research 2011 71 2 463 472